반려동물용 백신 시장 : 제품 유형별, 종별, 유통 채널별, 지역별
Companion Animal Vaccine Market, By Product Type, By Species Type , By Distribution Channel, By Geography
상품코드
:
1747508
리서치사
:
Coherent Market Insights
발행일
:
2025년 05월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
반려동물용 백신 시장은 2025년에는 38억 2,000만 달러로 추정되고, 2032년에는 60억 5,000만 달러에 이르며, 2025년부터 2032년까지의 CAGR은 6.8%를 나타낼 것으로 예측되고 있습니다.
| 보고 범위 |
보고서 세부정보 |
| 기준 연도 |
2024년 |
시장 규모(2025년) |
38억 2,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
6.80% |
가치 예측(2032년) |
60억 5,000만 달러 |
반려동물용 백신은 반려동물의 건강을 비용 효율적인 방식으로 개선하는 데 중요한 역할을 합니다. 미국 FDA 수의학 센터(CVM)는 개, 고양이, 말 등의 반려동물(반려동물), 소, 돼지, 닭 등의 식용 동물용의 의약품을 승인하고 있습니다. 질병과 같은 질병 예방에 대한 규제 당국의 노력이 증가하고 있음이 예측 기간에 걸쳐 세계의 반려동물 시장 성장을 뒷받침할 것으로 기대되고 있습니다. 예를 들어, 2016년 미국동물병원협회(AAHA)는 수의 종양학 전문가로 구성된 태스크포스를 구성하여 수의팀이 반려동물 보호자와 협력하여 암에 걸린 반려동물의 삶의 질을 개선할 수 있는 맞춤형 치료 계획을 세우는 데 도움이 되는 일련의 가이드라인을 개발하도록 의뢰했습니다.
시장 역학
신규 반려동물용 백신의 승인·출시 증가, 시장에서 사업을 전개하는 주요 기업에 의한 인수나 제휴 등의 무기적 성장 전략의 채용, 신규 백신의 연구개발 증가는 예측 기간에 걸쳐 세계의 반려동물용 백신 시장 성장을 가속할 것으로 예상됩니다. 예를 들어, 2019년 3월 프랑스 애니멀케어 기업인 Virbac사는 세계 여러 지역, 특히 남유럽과 남미에서 개리슈마니아증의 유병률이 증가하고 있기 때문에 개리슈마니아증을 예방하는 CANILEISH라는 백신을 발매했습니다.
게다가, 2018년 6월, Zoetis는 미국 농무부로부터 돼지 사코바이러스 2형(PCV2)의 2가지 유전자형을 포함한 돼지 고기 산업에 사용되는 최초의 1가 백신 Fostera Gold PCV의 판매 승인을 취득했습니다.
본 조사의 주요 특징
- 본 보고서는 세계의 반려동물용 백신 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
- 또, 다른 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 설명하고 있습니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 세계의 반려동물용 백신 시장에 있어서 주요 기업 프로파일을, 기업 개요, 업적, 제품 포트폴리오, 시장 프레즌스, 유통 전략, 주된 발전, 전략, 향후 계획 등의 파라미터에 근거해 제공합니다.
- 이 보고서로부터의 인사이트에 의해 기업의 마케팅 담당자나 경영진은 향후 시장 확대나 마케팅 전술에 관해서, 정보에 근거한 의사 결정을 실시할 수 있습니다.
- 세계의 반려동물용 백신 시장 보고서는 투자자, 제품 개발·제조자, 유통업체, 의료기관, 연구 개발 기관, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해 관계자를 대상으로 하고 있습니다.
- 세계의 반려동물용 백신 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 이해관계자는 의사결정에 있어서 큰 이익을 얻을 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 제품 출시/승인
- 역학
- 합병, 인수 및 협업
- 규제 시나리오
- 주요 발전
- PEST 분석
제4장 세계의 반려동물용 백신 시장, 제품 유형별(2020-2032년)
- 약독화 생백신
- 접합 백신
- 불활성화 백신
- 서브 유닛 백신
- 톡소이드 백신
- DNA 백신
- 유전자 재조합 백신
제5장 세계의 반려동물용 백신 시장, 종별(2020-2032년)
제6장 세계의 반려동물용 백신 시장, 유통 채널별(2020-2032년)
제7장 세계의 반려동물용 백신 시장, 지역별(2020-2032년)
- 북미
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 중동
- 아프리카
제8장 경쟁 구도
- 기업 프로파일
- Elanco Animal Health Incorporated
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck &Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, as
제9장 섹션
KTH
영문 목차
The Companion Animal Vaccine Market is estimated to be valued at USD 3.82 Bn in 2025 and is expected to reach USD 6.05 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 3.82 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
6.80% |
2032 Value Projection: |
USD 6.05 Bn |
Companion animal vaccines play an important role in improving the health of companion animals in a cost effective manner. These vaccines are also important for reducing viral diseases transmitted from animals to animals or animals to humans. The U.S. FDA Center for Veterinary Medicine (CVM) approves drugs for companion (pet) animals such as dogs, cats, and horses and for food-producing animals such as cattle, pigs, and chickens. Moreover, increasing initiatives from regulatory authorities for prevention of diseases such as viral diseases in companion animals are expected to boost the global companion animal market growth over the forecast period. For instance, in 2016, The American Animal Hospital Association (AAHA) has commissioned a task force of veterinary oncology experts to develop a set of guidelines that will help veterinary teams work with pet owners for tailored treatment plans that will improve the quality of life of pets with cancer.
Market Dynamics
The increasing approval and launch of novel companion vaccines, adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market, and rising research and development of novel vaccines are expected to drive the growth of global companion animal vaccine market over the forecast period. For instance, in March 2019, Virbac, a French animal care company, launched a vaccine called CANILEISH to prevent canine leishmaniosis, due to the increasing prevalence of canine leishmaniosis in several regions across the globe, especially in Southern Europe and South America.
Moreover, in June 2018, Zoetis received approval from the U.S. Department of Agriculture for marketing its first monovalent vaccine Fostera Gold PCV, used in the pork industry for swine that includes two genotypes of porcine circovirus type 2 (PCV2).
Key features of the study
- This report provides in-depth analysis of the global companion animal vaccine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global companion animal vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Virbac, Zoetis Inc, HIPRA, Biogenesis Bago, and Ourofino Animal Health.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics
- The global companion animal vaccine market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
- Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global companion animal vaccine market.
Market Segmentation
- Global Companion Animal Vaccine Market, By Product Type
- Attenuated Live Vaccine
- Conjugate Vaccine
- Inactivated Vaccine
- Subunit Vaccine
- Toxoid Vaccine
- DNA Vaccine
- Recombinant Vaccine
- Global Companion Animal Vaccine Market, By Animal Type
- Canine
- Feline
- Equine
- Others
- Global Companion Animal Vaccine Market, By Distribution Channel
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institute
- Others
- Global Companion Animal Vaccine Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Elanco Animal Health Incorporated
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck & Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health
- Croda International Plc
- KM Biologics
- Indian Immunological Ltd.
- Sinovac
- Kyoto Biken vLaboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Species Type
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Product Launches/Approvals
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Companion Animal Vaccine Market, By Product Type, 2020- 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Attenuated Live Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Subunit Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trend
- Recombinant Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trend
5. Global Companion Animal Vaccine Market, By Species Type, 2020- 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Canine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Feline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Equine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Avians
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
6. Global Companion Animal Vaccine Market, By Distribution Channel, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Veterinary Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
7. Global Companion Animal Vaccine Market, By Region, 2020 - 2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Elanco Animal Health Incorporated
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Boehringer Ingelheim GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Ceva Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Virbac
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Zoetis Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- HIPRA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Biogenesis Bago
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Ourofino Animal Health.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Croda International Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- KM Biologics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Indian Immunologicals Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sinovac
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Kyoto Biken Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- HESTER BIOSCIENCES LIMITED
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Calier
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bioveta, a.s
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
9. Section
- References
- Research Methodology
- About us and Sales Contact
관련자료
